Hemodynamic and Respiratory Effects of Esophageal Dilation in Children

NCT ID: NCT02512770

Last Updated: 2015-07-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-01-31

Study Completion Date

2015-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study compares hemodynamic and respiratory changes and complications in children who undergoing endoscopy for esophageal balloon dilatation and endoscopy for only control.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Esophageal strictures in children may develop as a secondary to a surgically repaired esophageal atresia (anastomatic strictures) or as a result of chemical injury after caustic ingestion. Emerging strictures are dilated with balloon catheter at regular intervals.

The possibility of various complications depending on the level of the stenosis during the dilation of esophagus. During Esophageal dilation may be pressed into airways and/or vascular structure.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obstruction of Esophagus Respiratory Complication Hemodynamic Instability

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

dilatation

esaphageal dilatation group

Group Type EXPERIMENTAL

endoscopic dilatation

Intervention Type PROCEDURE

control

control group ( only endoscopy for control)

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

endoscopic dilatation

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* endoscopy for esaphageal dilatation and control
* ASA I-III
* 0-16 year old

Exclusion Criteria

* ASA IV
* endoscopy for removing foreing body
Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ayse Cigdem Tutuncu

OTHER

Sponsor Role collaborator

Senol Emre

UNKNOWN

Sponsor Role collaborator

Fatis Altindas

UNKNOWN

Sponsor Role collaborator

Kaya, Guner, M.D.

INDIV

Sponsor Role collaborator

Istanbul University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

pinar kendigelen

M.D.(Anesthesiology Specialist)

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Guner Kaya, Prof.

Role: STUDY_DIRECTOR

Deapartment of Anesthesiology and Intensive Care, Cerrahpasa Medical Faculty,Istanbul University

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

270718

Identifier Type: -

Identifier Source: org_study_id